Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings Read more
Covance Launches Laboratory Data Management Functional Service Provider for Pharmaceutical and Biotechnology Customers Read more
Novartis PARAGON-HF trial suggests Entresto benefit in HFpEF patients but narrowly misses primary endpoint Read more
Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India Read more
EC approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer Read more